ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1046
0,02%
Bitcoin
69.309,78
4,58%
Brent Oil
83,48
-0,14%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. (MM) (DRTX)

  7. (MM) (DRTX) Notícias

DRTX

(MM) (DRTX)

(MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DRTX
DataHoraFonteTítuloCódigoCompanhia
12/12/201417:42Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DRTX(MM)
28/11/201412:56Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DRTX(MM)
19/11/201420:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRTX(MM)
19/11/201419:58Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRTX(MM)
19/11/201409:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DRTX(MM)
17/11/201419:47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DRTX(MM)
17/11/201419:35Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRTX(MM)
17/11/201419:18Edgar (US Regulatory)(25-NSE)NASDAQ:DRTX(MM)
17/11/201418:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRTX(MM)
17/11/201411:33Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DRTX(MM)
17/11/201411:23Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DRTX(MM)
17/11/201411:00PR Newswire (US)Actavis Successfully Completes Durata Therapeutics, Inc. Tender OfferNASDAQ:DRTX(MM)
07/11/201410:50Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DRTX(MM)
31/10/201418:15PR Newswire (US)Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of DurataNASDAQ:DRTX(MM)
17/10/201417:48Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:DRTX(MM)
17/10/201413:12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:DRTX(MM)
14/10/201413:36Business WireINVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Durata Therapeutics Inc. Concerning...NASDAQ:DRTX(MM)
11/10/201408:05Business WireSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Durata Therapeutics, Inc. in Connection with the Sale of t...NASDAQ:DRTX(MM)
10/10/201419:45PR Newswire (US)DURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) Over the Propos...NASDAQ:DRTX(MM)
10/10/201418:31Business WireDURATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNASDAQ:DRTX(MM)
10/10/201418:25Business WireSHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Durata Therapeutics, Inc. And Encourages ...NASDAQ:DRTX(MM)
09/10/201421:20PR Newswire (US)Harwood Feffer LLP Announces Investigation of Durata Therapeutics, Inc.NASDAQ:DRTX(MM)
08/10/201407:07Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DRTX(MM)
07/10/201419:29PR Newswire (US)Lifshitz & Miller Law Firm Announces Investigation of Altair Nanotechnologies, Inc., CareFusion, Durata Therapeutics, Inc., E...NASDAQ:DRTX(MM)
07/10/201417:34PR Newswire (US)INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Durata Therapeutics Inc. Regarding the...NASDAQ:DRTX(MM)
07/10/201411:45PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Durata Therapeutics, Inc.NASDAQ:DRTX(MM)
06/10/201420:15Business WireDURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) over the Propos...NASDAQ:DRTX(MM)
06/10/201419:18Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNASDAQ:DRTX(MM)
06/10/201418:11Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DRTX(MM)
06/10/201414:22Business WireGlancy Binkow & Goldberg LLP is Investigating Durata Therapeutics, Inc. Board of DirectorsNASDAQ:DRTX(MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:DRTX

Seu Histórico Recente

ASX
GEM
GE8 Education
ASX
TOP
Thorney Opportunities
POLO
LOOKSUSDT
LooksRare Token
EU
GRE5P
Euronext Green Planet E
USOTC
BCCMY
BAIC MTR (PK)
NASDAQ
AAXQDXX
BofA Finance LLC Issuer ...
NASDAQ
AAYPBXX
Bank of Montreal Capped ...
EU
BPCGA
BPCE Bpcefrn25may28
NASDAQ
AAZFJXX
Bank of Montreal Capped ...
COIN
MAFIAUSD
Crypto Mafia
ASX
NSMN
North Stawell Minerals
USOTC
LNDZF
Evome Medical Technologies (PK)
EU
XS1285080740
ABN Amro Bank NV 4.37% C...
AMEX
XFEB
FT Vest US Equity Enhanc...
BIT
S31942
Societe Generale Effekten
LSE
FB94
Permanent .73 A
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados